Through robust processes and internal protocols, we develop products as per the most stringent ICH guidelines. Ensuring our partners can register the products across markets with ease.
| PRODUCT NAME | PHARMACOPEIA | DMF | CEP Status |
|---|---|---|---|
| Nilotinib HCl Monohydrate | EP | ||
| Gemcitabine HCl | IP / EP / USP | ||
| Pemetrexed Disodium Heptahydrate | IP / EP / USP | ||
| Methotrexate | IP /BP/ EP / USP | ||
| Palbociclib | IH | ||
| Pazopanib HCl | IH | ||
| Enzalutamide | IH | ||
| Bendamustine HCl | IP / USP | ||
| Methotrexate Disodium | IH |
Discalimer
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and liability for infringement is exclusively understood at buyer’s risk.